0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query technavio global her 2 positive breast cancer market 2015 2019.Your search for "" gave back 1533058 results.
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) Drugs in Development by Stages, Target, MoA...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
The global Breast Cancer Monoclonal Antibodies market size was valued at US$ million in 2023. With growing demand in downstream market, the Breast...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Women’s Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are...
Catalog:
CBR Pharma Insights
January 2015
Price: USD 2,995.00
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Trastuzumab market size was valued at US$ million in 2023. With growing demand in downstream market, the Trastuzumab is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global HER2 Tumor Marker Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The global HER2 Tumor Marker Testing market size was valued at US$ million in 2022. With growing demand in downstream market, the HER2 Tumor Marker...
Catalog:
LPI
November 2023
Price: USD 3,660.00
The global HER2 Tumor Marker Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
November 2023
Price: USD 4,480.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
Catalog:
Global Markets Direct
October 2022
Price: USD 3,500.00
Estrogen Receptor - Pipeline Review, H2 2019 Summary Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021 Summary Insulin Like Growth Factor...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
